Tower Wealth Partners Inc. Increases Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Tower Wealth Partners Inc. increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 7.7% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,050 shares of the healthcare conglomerate’s stock after buying an additional 75 shares during the quarter. Tower Wealth Partners Inc.’s holdings in UnitedHealth Group were worth $519,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of UNH. Ameriprise Financial Inc. increased its holdings in UnitedHealth Group by 20.1% in the third quarter. Ameriprise Financial Inc. now owns 3,725,650 shares of the healthcare conglomerate’s stock valued at $1,879,245,000 after buying an additional 623,631 shares during the last quarter. Alps Advisors Inc. raised its position in shares of UnitedHealth Group by 111.0% during the 3rd quarter. Alps Advisors Inc. now owns 40,915 shares of the healthcare conglomerate’s stock valued at $20,629,000 after acquiring an additional 21,526 shares in the last quarter. Adage Capital Partners GP L.L.C. increased its stake in UnitedHealth Group by 10.0% during the third quarter. Adage Capital Partners GP L.L.C. now owns 925,866 shares of the healthcare conglomerate’s stock valued at $466,812,000 after purchasing an additional 84,215 shares during the last quarter. Evergreen Capital Management LLC boosted its holdings in shares of UnitedHealth Group by 3.2% in the 3rd quarter. Evergreen Capital Management LLC now owns 16,786 shares of the healthcare conglomerate’s stock valued at $8,463,000 after buying an additional 519 shares during the period. Finally, Elevatus Welath Management acquired a new position in UnitedHealth Group in the third quarter valued at approximately $226,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Up 0.7 %

Shares of NYSE:UNH opened at $498.13 on Wednesday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70. The firm has a fifty day moving average of $498.40 and a two-hundred day moving average of $501.35. The firm has a market capitalization of $458.47 billion, a P/E ratio of 30.45, a price-to-earnings-growth ratio of 1.48 and a beta of 0.60.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm’s revenue was up 8.6% on a year-over-year basis. During the same period in the previous year, the company earned $6.26 EPS. On average, equities analysts expect that UnitedHealth Group Incorporated will post 27.55 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Monday, June 17th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, June 17th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.69%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s payout ratio is currently 51.34%.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on UNH shares. Robert W. Baird started coverage on UnitedHealth Group in a research note on Thursday, May 30th. They set an “outperform” rating and a $597.00 price objective for the company. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 price target on the stock in a report on Wednesday, June 5th. Truist Financial reiterated a “buy” rating and set a $600.00 price target on shares of UnitedHealth Group in a research report on Wednesday, April 17th. TD Cowen reduced their price objective on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a report on Wednesday, April 10th. Finally, Baird R W upgraded shares of UnitedHealth Group to a “strong-buy” rating in a research report on Thursday, May 30th. Three investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus target price of $579.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.